Literature DB >> 10419025

Glucocorticoids, oxysterols, and cAMP with glucocorticoids each cause apoptosis of CEM cells and suppress c-myc.

E B Thompson1, R D Medh, F Zhou, S Ayala-Torres, N Ansari, W Zhang, B H Johnson.   

Abstract

In clones of the CEM human acute lymphoblastic leukemic cell line, glucocorticoids, oxysterols and activators of the cAMP pathway acting synergistically with glucocorticoids, each can cause apoptotic cell death. Morphologically and kinetically, these deaths resemble one another. The kinetics are striking: in each case, after addition of the lethal compound(s), an interval of approximately 24 h follows, during which cell growth continues unabated. During this "prodromal" period, removal of the apoptotic agent leaves the cells fully viable. We hypothesize that a sequence of biochemical events occurs during the prodrome which eventually results in the triggering of the full apoptotic response as evidenced by the activation of caspases and DNA fragmentation. At some point, the process is irreversible and proceeds relatively rapidly to cell death. Suppression of c-Myc seems a universal early event evoked by each of these lethal compounds or combinations, and we conclude that the negative regulation of this proto-oncogene is an important aspect of the critical pre-apoptotic events in these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419025      PMCID: PMC2768316          DOI: 10.1016/s0960-0760(99)00063-1

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  31 in total

1.  Stabilization of c-myc protein in human glioma cells.

Authors:  H Shindo; E Tani; T Matsumuto; T Hashimoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.

Authors:  R Thulasi; D V Harbour; E B Thompson
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

3.  Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.

Authors:  S K Nordeen; B J Bona; M L Moyer
Journal:  Mol Endocrinol       Date:  1993-06

4.  Oxysterol-induced cell death in human leukemic T-cells correlates with oxysterol binding protein occupancy and is independent of glucocorticoid-induced apoptosis.

Authors:  J T Bakos; B H Johnson; E B Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  1993-10       Impact factor: 4.292

5.  Characterization of the human oxysterol receptor overexpressed in the baculovirus system.

Authors:  G Srinivasan; N T Patel; E B Thompson
Journal:  Receptor       Date:  1993

6.  Synergistic induction of apoptosis with glucocorticoids and 3',5'-cyclic adenosine monophosphate reveals agonist activity by RU 486.

Authors:  D J Gruol; J Altschmied
Journal:  Mol Endocrinol       Date:  1993-01

7.  Existence of a commitment program for mitosis in early G1 in tumour cells.

Authors:  O Larsson; A Zetterberg
Journal:  Cell Prolif       Date:  1995-01       Impact factor: 6.831

8.  Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation.

Authors:  D G Brown; X M Sun; G M Cohen
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

9.  Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells.

Authors:  E B Thompson; R Thulasi; M F Saeed; B H Johnson
Journal:  Ann N Y Acad Sci       Date:  1995-06-12       Impact factor: 5.691

10.  Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor.

Authors:  A Helmberg; N Auphan; C Caelles; M Karin
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  7 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A.

Authors:  Alexander C Zambon; Lingzhi Zhang; Simon Minovitsky; Joan R Kanter; Shyam Prabhakar; Nathan Salomonis; Karen Vranizan; Inna Dubchak; Bruce R Conklin; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

3.  Ascl1-induced neuronal differentiation of P19 cells requires expression of a specific inhibitor protein of cyclic AMP-dependent protein kinase.

Authors:  Holly S Huang; David L Turner; Robert C Thompson; Michael D Uhler
Journal:  J Neurochem       Date:  2011-06-24       Impact factor: 5.372

4.  The delayed induction of c-jun in apoptotic human leukemic lymphoblasts is primarily transcriptional.

Authors:  F Zhou; R D Medh; W Zhang; N H Ansari; E B Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2000-12-15       Impact factor: 4.292

5.  Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.

Authors:  N Pottier; S W Paugh; C Ding; D Pei; W Yang; S Das; E H Cook; C-H Pui; M V Relling; M H Cheok; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2010-10-27       Impact factor: 6.875

Review 6.  Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

Authors:  P A Insel; L Zhang; F Murray; H Yokouchi; A C Zambon
Journal:  Acta Physiol (Oxf)       Date:  2011-05-26       Impact factor: 6.311

7.  Inhibition of autophagy overcomes glucocorticoid resistance in lymphoid malignant cells.

Authors:  Lei Jiang; Lingzhi Xu; Jiajun Xie; Sisi Li; Yanchun Guan; Yan Zhang; Zhijie Hou; Tao Guo; Xin Shu; Chang Wang; Wenjun Fan; Yang Si; Ya Yang; Zhijie Kang; Meiyun Fang; Quentin Liu
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.